You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


How Can Interstitial Lung Disease Phenotypes Guide Care? Experts Weigh in on ILDs With Progressive Phenotypes

  • Authors: Kevin R. Flaherty, MD; Rebecca C. Keith, MD
  • CME / ABIM MOC Released: 11/10/2022
  • Valid for credit through: 11/10/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for pulmonologists, radiologists, pathologists and other clinicians who care for patients with ILD.

The goal of this activity is for learners to be better able to recognize and diagnose chronic fibrosing ILDs with a progressive phenotype and initiate timely management of these patients accordingly.

Upon completion of this activity, participants will:

  • Distinguish types of ILD associated with a risk of developing a progressive fibrosing phenotype
  • Assess factors that reflect progression of ILDs
  • Select the care plan for patients with ILDs with a progressive fibrosing phenotype in the context of a multidisciplinary care team


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


  • Kevin R. Flaherty, MD

    Professor of Internal Medicine
    Michigan Medicine Interstitial Lung Disease Program
    University of Michigan
    Ann Arbor, Michigan


    Kevin R. Flaherty, MD, has the following relevant financial relationships:
    Consultant or advisor for: Arrowhead; AstraZeneca; Bellerophon; CSL Behring; Daewong; Dispersol; DevPro; Fibrogen; Horizon; Immumet; Insilco; Lupin; NeRRe Therapeutics; Pliant; Polarean; Pure Health; PureTech; Respivant; Roche/Genentech; Shionogi; Sun Pharmaceuticals; Trevi; United Therapeutics
    Contracted researcher for: Boehringer Ingelheim

  • Rebecca C. Keith, MD

    Associate Professor of Medicine 
    Division of Pulmonary 
    Critical Care and Sleep Medicine 
    Interstitial Lung Disease Program
    Autoimmune Lung Center
    National Jewish Health
    Denver, Colorado


    Rebecca C. Keith, MD, has the following relevant financial relationships:
    Consultant or advisor for: Boehringer Ingelheim
    Speaker or member of speakers bureau for: Boehringer Ingelheim


  • Karen Badal, MD, MPH

    Senior Medical Education Director, Medscape, LLC


    Karen Badal, MD, MPH, has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


How Can Interstitial Lung Disease Phenotypes Guide Care? Experts Weigh in on ILDs With Progressive Phenotypes

Authors: Kevin R. Flaherty, MD; Rebecca C. Keith, MDFaculty and Disclosures

CME / ABIM MOC Released: 11/10/2022

Valid for credit through: 11/10/2023, 11:59 PM EST


Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print